|
Name |
Comazaphilone D
|
| Molecular Formula | C21H22O7 | |
| IUPAC Name* |
[(6R,7R)-7-hydroxy-7-methyl-8-oxo-3-[(E)-prop-1-enyl]-5,6-dihydro-1H-isochromen-6-yl] 2,4-dihydroxy-6-methylbenzoate
|
|
| SMILES |
C/C=C/C1=CC2=C(CO1)C(=O)[C@]([C@@H](C2)OC(=O)C3=C(C=C(C=C3C)O)O)(C)O
|
|
| InChI |
InChI=1S/C21H22O7/c1-4-5-14-7-12-8-17(21(3,26)19(24)15(12)10-27-14)28-20(25)18-11(2)6-13(22)9-16(18)23/h4-7,9,17,22-23,26H,8,10H2,1-3H3/b5-4+/t17-,21-/m1/s1
|
|
| InChIKey |
GIROBNCADSJPIJ-OQBWYENPSA-N
|
|
| Synonyms |
Comazaphilone D; CHEBI:70013; MLS005941364; CHEMBL1689198; SMR004614078; Q27138354; (6R,7R)-7-Hydroxy-7-methyl-8-oxo-3-[prop-1-en-1-yl]-5,6,7,8-tetrahydro-1H-isochromen-6-yl 2,4-dihydroxy-6-methylbenzoate; [(6R,7R)-7-hydroxy-7-methyl-8-oxo-3-[(E)-prop-1-enyl]-5,6-dihydro-1H-isochromen-6-yl] 2,4-dihydroxy-6-methyl-benzoate; rel-(6R,7R)-7-hydroxy-7-methyl-8-oxo-3-[(1E)-prop-1-en-1-yl]-5,6,7,8-tetrahydro-1H-isochromen-6-yl 2,4-dihydroxy-6-methylbenzoate
|
|
| CAS | NA | |
| PubChem CID | 51041753 | |
| ChEMBL ID | CHEMBL1689198 |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 386.4 | ALogp: | 2.6 |
| HBD: | 3 | HBA: | 7 |
| Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 113.0 | Aromatic Rings: | 3 |
| Heavy Atoms: | 28 | QED Weighted: | 0.684 |
| Caco-2 Permeability: | -4.925 | MDCK Permeability: | 0.00001800 |
| Pgp-inhibitor: | 0.006 | Pgp-substrate: | 0.044 |
| Human Intestinal Absorption (HIA): | 0.019 | 20% Bioavailability (F20%): | 0.782 |
| 30% Bioavailability (F30%): | 0.24 |
| Blood-Brain-Barrier Penetration (BBB): | 0.022 | Plasma Protein Binding (PPB): | 94.97% |
| Volume Distribution (VD): | 0.846 | Fu: | 3.18% |
| CYP1A2-inhibitor: | 0.968 | CYP1A2-substrate: | 0.509 |
| CYP2C19-inhibitor: | 0.596 | CYP2C19-substrate: | 0.067 |
| CYP2C9-inhibitor: | 0.739 | CYP2C9-substrate: | 0.876 |
| CYP2D6-inhibitor: | 0.953 | CYP2D6-substrate: | 0.324 |
| CYP3A4-inhibitor: | 0.839 | CYP3A4-substrate: | 0.209 |
| Clearance (CL): | 5.225 | Half-life (T1/2): | 0.843 |
| hERG Blockers: | 0.01 | Human Hepatotoxicity (H-HT): | 0.402 |
| Drug-inuced Liver Injury (DILI): | 0.942 | AMES Toxicity: | 0.278 |
| Rat Oral Acute Toxicity: | 0.397 | Maximum Recommended Daily Dose: | 0.964 |
| Skin Sensitization: | 0.948 | Carcinogencity: | 0.866 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.878 |
| Respiratory Toxicity: | 0.25 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002211 | ![]() |
0.845 | D07MGA | ![]() |
0.280 | ||
| ENC003837 | ![]() |
0.826 | D08NQZ | ![]() |
0.250 | ||
| ENC002132 | ![]() |
0.791 | D0R6RC | ![]() |
0.237 | ||
| ENC005503 | ![]() |
0.652 | D0J2NK | ![]() |
0.237 | ||
| ENC002131 | ![]() |
0.649 | D08LTU | ![]() |
0.235 | ||
| ENC003304 | ![]() |
0.635 | D04AIT | ![]() |
0.229 | ||
| ENC002606 | ![]() |
0.583 | D02PMO | ![]() |
0.227 | ||
| ENC003451 | ![]() |
0.539 | D0H0SJ | ![]() |
0.227 | ||
| ENC003450 | ![]() |
0.539 | D02GAC | ![]() |
0.226 | ||
| ENC003615 | ![]() |
0.536 | D05AFR | ![]() |
0.226 | ||